A Commentary on the 1995 Cold Spring Harbor Laboratory Meeting, "Mechanisms of Eukaryot C Transcription"
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Supplemental Materials
SUPPLEMENTAL MATERIALS Simple biochemical features underlie transcriptional activation domain diversity and dynamic, fuzzy binding to Mediator Adrian L. Sanborn,1,2,* Benjamin T. Yeh,2 Jordan T. Feigerle,1 Cynthia V. Hao,1 Raphael J. L. Townshend,2 Erez Lieberman Aiden,3,4 Ron O. Dror,2 Roger D. Kornberg1,*,+ 1Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305, USA 2Department of Computer Science, Stanford University, Stanford, CA 94305, USA 3The Center for Genome Architecture, Baylor College of Medicine, Houston, USA 4Center for Theoretical Biological Physics, Rice University, Houston, USA *Correspondence: [email protected], [email protected] +Lead Contact 1 A B Empty GFP Count Count Count VP16 AD mCherry mCherry GFP C G Count 2 AD tiles 10 Random sequences 2 12 10 10 Gcn4 AD 8 1 10 1 6 10 Z-score Activation 4 Count 2 0 Activation, second library 0 10 0 10 Gal4 Gln3 Hap4 Ino2 Ino2 Msn2 Oaf1 Pip2 VP16 VP64 r = 0.952 Pho4 AD 147 104 112 1 108 234 995 944 0 1 2 Synonymously encoded control ADs 10 10 10 Activation, first library Count H 102 GFP 101 D E Empty VP16 activation 100 80% Mean positional VP16 AD 0 200 400 600 800 1000 1200 60% Position in Adr1 protein 40% By FACS GFP By sequencing I 20% 50% 0% Percent of cells 1 2 3 4 5 6 7 8 mCherry mCherry 25% 80% Gcn4 AD 60% Empty VP16 0% 40% AD at position with Percent of proteins 0.0 0.2 0.4 0.6 0.8 1.0 20% Position on protein, normalized 0% Percent of cells 100% 1 2 3 4 5 6 7 8 100% 80% 75% 75% Pho4 AD / mCherry ratio GFP 60% GFP GFP 50% 50% 40% 20% 25% 25% C-term ADs 0% ADs Percent of Percent of cells Other ADs 0% 1 2 3 4 5 6 7 8 0% 1 2 F 25 50 75 100 125 10 10 Gcn4 hydrophobic mutants (cumulative distribution) GFP bin number 1 AD length Activation J 1.0 0 0.8 0.6 0.4 −1 (log2 change vs wild-type) 0.2 Frequency of aTF expression 5 10 15 TFs without ADs falling within sorted mCh range Hydrophobic content 0.0 TFs with ADs Cumulative fraction of TFs (kcal/mol) 0.0 0.2 0.4 0.6 0.8 1.0 Fraction of genes regulated by TF that are activating Figure S1. -
Chromatin Dynamics in The
TRANSCRIPTION AND CHROMATIN DYNAMICS IN THE NOTCH SIGNALLING RESPONSE Zoe Pillidge Churchill College Department of Physiology, Development and Neuroscience University of Cambridge This dissertation is submitted for the degree of Doctor of Philosophy September 2018 TRANSCRIPTION AND CHROMATIN DYNAMICS IN THE NOTCH SIGNALLING RESPONSE During normal development, different genes are expressed in different cell types, often directed by cell signalling pathways and the pre-existing chromatin environment. The highly-conserved Notch signalling pathway is involved in many cell fate decisions during development, activating different target genes in different contexts. Upon ligand binding, the Notch receptor itself is cleaved, allowing the intracellular domain to travel to the nucleus and activate gene expression with the transcription factor known as Suppressor of Hairless (Su(H)) in Drosophila melanogaster. It is remarkable how, with such simplicity, the pathway can have such diverse outcomes while retaining precision, speed and robustness in the transcriptional response. The primary goal of this PhD has been to gain a better understanding of this process of rapid transcriptional activation in the context of the chromatin environment. To learn about the dynamics of the Notch transcriptional response, a live imaging approach was used in Drosophila Kc167 cells to visualise the transcription of a Notch-responsive gene in real time. With this technique, it was found that Notch receptor cleavage and trafficking can take place within 15 minutes to activate target gene expression, but that a ligand-receptor interaction between neighbouring cells may take longer. These experiments provide new data about the dynamics of the Notch response which could not be obtained with static time-point experiments. -
Investigating the Role of the ETS Transcription Factor ELK1 in Stem Cell Transcription
Investigating the role of the ETS transcription factor ELK1 in stem cell transcription A thesis submitted to the University of Manchester for the degree of Doctor of Philosophy in the Faculty of Biology, Medicine and Health 2017 Ian E. Prise Division of Molecular & Cellular Function School of Biological Sciences I. Table of Contents II. List of Figures ...................................................................................................................................... 5 III. Abstract .............................................................................................................................................. 7 IV. Declaration ......................................................................................................................................... 8 V. Copyright Statement ........................................................................................................................... 8 VI. Experimental Contributions ............................................................................................................... 9 VII. Acknowledgments .......................................................................................................................... 10 1. Introduction ...................................................................................................................................... 12 1.I Pluripotency ................................................................................................................................. 12 1.II Chromatin -
Intrinsic Specificity of DNA Binding and Function of Class II Bhlh
INTRINSIC SPECIFICITY OF BINDING AND REGULATORY FUNCTION OF CLASS II BHLH TRANSCRIPTION FACTORS APPROVED BY SUPERVISORY COMMITTEE Jane E. Johnson Ph.D. Helmut Kramer Ph.D. Genevieve Konopka Ph.D. Raymond MacDonald Ph.D. INTRINSIC SPECIFICITY OF BINDING AND REGULATORY FUNCTION OF CLASS II BHLH TRANSCRIPTION FACTORS by BRADFORD HARRIS CASEY DISSERTATION Presented to the Faculty of the Graduate School of Biomedical Sciences The University of Texas Southwestern Medical Center at Dallas In Partial Fulfillment of the Requirements For the Degree of DOCTOR OF PHILOSOPHY The University of Texas Southwestern Medical Center at Dallas Dallas, Texas December, 2016 DEDICATION This work is dedicated to my family, who have taught me pursue truth in all forms. To my grandparents for inspiring my curiosity, my parents for teaching me the value of a life in the service of others, my sisters for reminding me of the importance of patience, and to Rachel, who is both “the beautiful one”, and “the smart one”, and insists that I am clever and beautiful, too. Copyright by Bradford Harris Casey, 2016 All Rights Reserved INTRINSIC SPECIFICITY OF BINDING AND REGULATORY FUNCTION OF CLASS II BHLH TRANSCRIPTION FACTORS Publication No. Bradford Harris Casey The University of Texas Southwestern Medical Center at Dallas, 2016 Jane E. Johnson, Ph.D. PREFACE Embryonic development begins with a single cell, and gives rise to the many diverse cells which comprise the complex structures of the adult animal. Distinct cell fates require precise regulation to develop and maintain their functional characteristics. Transcription factors provide a mechanism to select tissue-specific programs of gene expression from the shared genome. -
CHD7 Represses the Retinoic Acid Synthesis Enzyme ALDH1A3 During Inner Ear Development
CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development Hui Yao, … , Shigeki Iwase, Donna M. Martin JCI Insight. 2018;3(4):e97440. https://doi.org/10.1172/jci.insight.97440. Research Article Development Neuroscience CHD7, an ATP-dependent chromatin remodeler, is disrupted in CHARGE syndrome, an autosomal dominant disorder characterized by variably penetrant abnormalities in craniofacial, cardiac, and nervous system tissues. The inner ear is uniquely sensitive to CHD7 levels and is the most commonly affected organ in individuals with CHARGE. Interestingly, upregulation or downregulation of retinoic acid (RA) signaling during embryogenesis also leads to developmental defects similar to those in CHARGE syndrome, suggesting that CHD7 and RA may have common target genes or signaling pathways. Here, we tested three separate potential mechanisms for CHD7 and RA interaction: (a) direct binding of CHD7 with RA receptors, (b) regulation of CHD7 levels by RA, and (c) CHD7 binding and regulation of RA-related genes. We show that CHD7 directly regulates expression of Aldh1a3, the gene encoding the RA synthetic enzyme ALDH1A3 and that loss of Aldh1a3 partially rescues Chd7 mutant mouse inner ear defects. Together, these studies indicate that ALDH1A3 acts with CHD7 in a common genetic pathway to regulate inner ear development, providing insights into how CHD7 and RA regulate gene expression and morphogenesis in the developing embryo. Find the latest version: https://jci.me/97440/pdf RESEARCH ARTICLE CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development Hui Yao,1 Sophie F. Hill,2 Jennifer M. Skidmore,1 Ethan D. Sperry,3,4 Donald L. -
An Initiator Element Mediates Autologous Down- Regulation of the Human Type a ␥-Aminobutyric Acid Receptor 1 Subunit Gene
An initiator element mediates autologous down- regulation of the human type A ␥-aminobutyric acid receptor 1 subunit gene Shelley J. Russek, Sabita Bandyopadhyay, and David H. Farb* Laboratory of Molecular Neurobiology, Department of Pharmacology, Boston University School of Medicine, 80 East Concord Street, Boston, MA 02118 Edited by Erminio Costa, University of Illinois, Chicago, IL, and approved May 15, 2000 (received for review November 19, 1999) The regulated expression of type A ␥-aminobutyric acid receptor The 1 subunit gene is located in the 1-␣4-␣2-␥1 gene cluster (GABAAR) subunit genes is postulated to play a role in neuronal on chromosome 4 (12) and is most highly expressed in the adult maturation, synaptogenesis, and predisposition to neurological rat hippocampus. Seizure activity decreases hippocampal 1 disease. Increases in GABA levels and changes in GABAAR subunit mRNA levels by about 50% while increasing 3 levels (11). gene expression, including decreased 1 mRNA levels, have been Because the subtype of  subunit influences the sensitivity of the observed in animal models of epilepsy. Persistent exposure to GABAAR to GABA and to allosteric modulators such as GABA down-regulates GABAAR number in primary cultures of etomidate, loreclezole, barbiturates, and mefenamic acid (13– neocortical neurons, but the regulatory mechanisms remain un- 17), a change in  subunit composition may alter receptor known. Here, we report the identification of a TATA-less minimal function and pharmacology in vivo. Modulation of receptor  promoter of 296 bp for the human GABAAR 1 subunit gene that function by phosphorylation is also influenced by subunit is neuron specific and autologously down-regulated by GABA. -
Oncjuly3 6..6
Oncogene (1999) 18, 4137 ± 4143 ã 1999 Stockton Press All rights reserved 0950 ± 9232/99 $12.00 http://www.stockton-press.co.uk/onc Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site Takeshi Suzuki1, Masami Uchida-Toita1 and Mitsuaki Yoshida*,1 1Department of Cellular and Molecular Biology, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan Tax protein of human T-cell leukemia virus type 1 Tax was originally identi®ed as a transcriptional (HTLV-1) is a potent transcriptional regulator which can activator for viral gene expression and then was shown activate or repress speci®c cellular genes and has been to activate a wide variety of cellular genes (Yoshida et proposed to contribute to leukemogenic processes in al., 1995). Tax was also demonstrated to inhibit adult T-cell leukemia. The molecular mechanism of Tax- expression of several genes. In addition to the mediated trans-activation has been well investigated. transcriptional deregulation, we found that Tax binds However, trans-repression by Tax remains to be studied to p16ink4a protein, a cyclin-dependent kinase (CDK) in detail, although it is known to require a speci®c DNA inhibitor, and suppresses its inhibitory activity pre- element such as E-box or p53 binding site. Examining venting the cell from undergoing growth arrest (Suzuki possible mechanisms of trans-repression, we found that et al., 1996). These pleiotropic functions of Tax aect co-expression of E47 and p300 activated E-box multiple regulatory processes of cells and are believed dependent transcription and this activation was eciently to play roles at least in the initial stage of repressed by Tax. -
Transcrip\Onal and Epigene\C Changes During Heart Disease
786/110 Transcrip)onal and Epigene)c Changes during Heart Disease Danish Sayed Unique Features of Heart • Involuntary, rhythmic, cyclic contractions • Terminally differentiated, postnatal myocytes increase in size not numbers for growth • Number of non myocytes (e.g. fibroblasts) is more (60-70%) compared to number of myocytes (~30%). Neonate Heart Postnatal Growth “Physiological” Adult Heart - Exercise - Hypertension - Pregnancy - Aortic Stenosis - Sarcomeric Gene mutation - Myocardial Infarction - Dilated Cardiomyopathy Physiological Pathological Hypertrophy Hypertrophy Dilatation and Failure Compensatory Decompensation Overload • Increase in cardiomyocyte size • Chamber dilatation and mass, resulting in enlarged heart • Decreased Ventricular Wall • Increase in generalized gene Thickness and Increased expression, superimposed with wall tension significant increase in specialized genes, fetal gene • Altered Ca+2 handling program • Increased wall thickness • Increased myocardial • Switch to glucose metabolism apoptosis for energy Compromised Maintained Cardiac Cardiac function and Function and Output Output Modulators of Cardiac Hypertrophy L-Type Ca+2 Ang II, ET-1 Channel α-Adrenergic β-Adrenergic Mechanical Ca+2 Insulin-like Growth Stretch + Factor Na Gq Gs P Ca+2 PKA PLC Adenylyl Integrin Cyclase Ca+2 RAS-GTP Na+ PI3K IP3 DAG cAMP Calcineurine FAK AKT Ca+2 Rho PKC PKA Ras mTOR Rac GSK3β 4EBP1 Rock MLCK NFAT MAPK eIF2B p70S6K eIF4E ME ME ME ME GATA4 GATA4 MEF2 Sarcomere SRF Translation AC AC Transcription HDAC Histone Acetylation HAT Modificatn. Methylation HMT Chromatin Demethylases Remodeling Phosphorylation DNA Methylation Transcriptional Modificatn. General Factors Transcription factors TFIIA, TFIIB, TFIID… Promoter Specific Factors GATA family, NFATc family Activity Recruitment Gene Regulation RNA Polymerase II Dynamics Initiation Elongation Translation factors e.g. -
Repressor to Activator Switch by Mutations in the First Zn Finger of The
Proc. Nat!. Acad. Sci. USA Vol. 88, pp. 7086-7090, August 1991 Biochemistry Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: Is direct DNA binding necessary? (interleukin 1 indudbility/dexamethasone modulation/DNA-binding domain mutants/interleukin 6 and c-fos promoters) ANURADHA RAY, K. STEVEN LAFORGE, AND PRAVINKUMAR B. SEHGAL* The Rockefeller University, New York, NY 10021 Communicated by Igor Tamm, May 20, 1991 (receivedfor review March 15, 1991) ABSTRACT Transfection ofHeLa cells with cDNA vectors previous experiments in HeLa cells transfected with cDNA expressing the wild-type human glucocorticoid receptor (GR) vectors constitutively expressing the wild type (wt) but not enabled dexamethasone to strongly repress cytokine- and sec- the inactive carboxyl-terminal truncation mutants of GR, we ond messenger-induced expression of cotransfected chimeric observed that dexamethasone (Dex) strongly repressed the reporter genes containing transcription regulatory DNA ele- induction by interleukin 1 (IL-1), tumor necrosis factor, ments from the human interleukin 6 (IL-6) promoter. Deletion phorbol ester, or forskolin of IL-6-chloramphenicol acetyl- of the DNA-binding domain or of the second Zn finger or a transferase (CAT) constructs containing IL-6 DNA from point mutation in the Zn catenation site in the second finger -225 to +13. Dex also repressed induction of IL-6- blocked the ability of GR to mediate repression of the IL-6 thymidine kinase (TK)-CAT chimeric constructs containing promoter. -
An Activation-Specific Role for Transcription Factor TFIIB in Vivo (Sua7͞pho4͞pho5͞transcriptional Control)
Proc. Natl. Acad. Sci. USA Vol. 96, pp. 2764–2769, March 1999 Biochemistry An activation-specific role for transcription factor TFIIB in vivo (SUA7yPho4yPHO5ytranscriptional control) WEI-HUA WU AND MICHAEL HAMPSEY* Department of Biochemistry, Division of Nucleic Acids Enzymology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854-5635 Edited by Robert G. Roeder, The Rockefeller University, New York, NY, and approved January 20, 1999 (received for review November 9, 1998) ABSTRACT A yeast mutant was isolated encoding a sin- a study of PIC formation and transcriptional activity demon- gle amino acid substitution [serine-53 3 proline (S53P)] in strated that PIC assembly occurs by at least two steps and that transcription factor TFIIB that impairs activation of the the TATA box and TFIIB also can affect transcription subse- PHO5 gene in response to phosphate starvation. This effect is quent to PIC assembly (11). Thus, processes other than factor activation-specific because S53P did not affect the uninduced recruitment are potential activator targets. level of PHO5 expression, yet is not specific to PHO5 because TFIIB is recruited to the PIC by the acidic activator VP16 Adr1-mediated activation of the ADH2 gene also was impaired and the proline-rich activator CTF1 (3, 12). VP16 directly by S53P. Pho4, the principal activator of PHO5, directly targets TFIIB (3) and this interaction is required for activation interacted with TFIIB in vitro, and this interaction was (13, 14). Interestingly, VP16 induces a conformational change impaired by the S53P replacement. Furthermore, Pho4 in- in TFIIB that disrupts the intramolecular interaction between duced a conformational change in TFIIB, detected by en- the N- and C-terminal domains in solution (15). -
The HLH-6 Transcription Factor Regulates C
The HLH-6 Transcription Factor Regulates C. elegans Pharyngeal Gland Development and Function Ryan B. Smit1, Ralf Schnabel2, Jeb Gaudet1,3* 1 Genes and Development Research Group, Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada, 2 Institut fu¨r Genetik, Technische Universita¨t Braunschweig, Braunschweig, Germany, 3 Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada Abstract The Caenorhabditis elegans pharynx (or foregut) functions as a pump that draws in food (bacteria) from the environment. While the ‘‘organ identity factor’’ PHA-4 is critical for formation of the C. elegans pharynx as a whole, little is known about the specification of distinct cell types within the pharynx. Here, we use a combination of bioinformatics, molecular biology, and genetics to identify a helix-loop-helix transcription factor (HLH-6) as a critical regulator of pharyngeal gland development. HLH-6 is required for expression of a number of gland-specific genes, acting through a discrete cis-regulatory element named PGM1 (Pharyngeal Gland Motif 1). hlh-6 mutants exhibit a frequent loss of a subset of glands, while the remaining glands have impaired activity, indicating a role for hlh-6 in both gland development and function. Interestingly, hlh-6 mutants are also feeding defective, ascribing a biological function for the glands. Pharyngeal pumping in hlh-6 mutants is normal, but hlh-6 mutants lack expression of a class of mucin-related proteins that are normally secreted by pharyngeal glands and line the pharyngeal cuticle. An interesting possibility is that one function of pharyngeal glands is to secrete a pharyngeal lining that ensures efficient transport of food along the pharyngeal lumen. -
Focused Transcription from the Human CR2/CD21 Core Promoter Is Regulated by Synergistic Activity of TATA and Initiator Elements in Mature B Cells
Cellular & Molecular Immunology (2016) 13, 119–131 ß 2015 CSI and USTC. All rights reserved 1672-7681/15 $32.00 www.nature.com/cmi RESEARCH ARTICLE Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells Rhonda L Taylor1,2, Mark N Cruickshank3, Mahdad Karimi2, Han Leng Ng1, Elizabeth Quail2, Kenneth M Kaufman4,5, John B Harley4,5, Lawrence J Abraham1, Betty P Tsao6, Susan A Boackle7 and Daniela Ulgiati1 Complement receptor 2 (CR2/CD21) is predominantly expressed on the surface of mature B cells where it forms part of a coreceptor complex that functions, in part, to modulate B-cell receptor signal strength. CR2/CD21 expression is tightly regulated throughout B-cell development such that CR2/CD21 cannot be detected on pre-B or terminally differentiated plasma cells. CR2/CD21 expression is upregulated at B-cell maturation and can be induced by IL-4 and CD40 signaling pathways. We have previously characterized elements in the proximal promoter and first intron of CR2/CD21 that are involved in regulating basal and tissue-specific expression. We now extend these analyses to the CR2/CD21 core promoter. We show that in mature B cells, CR2/CD21 transcription proceeds from a focused TSS regulated by a non-consensus TATA box, an initiator element and a downstream promoter element. Furthermore, occupancy of the general transcriptional machinery in pre-B versus mature B-cell lines correlate with CR2/CD21 expression level and indicate that promoter accessibility must switch from inactive to active during the transitional B-cell window.